Financial support: This study was supported by the Brain Foundation (Australia), National Health and Medical Research Council #454606 (Australia) and, in part, with funding from the NIH NS047113 to AHA.
5-HT1D Receptor Immunoreactivity in the Sphenopalatine Ganglion: Implications for the Efficacy of Triptans in the Treatment of Autonomic Signs Associated With Cluster Headache
Version of Record online: 25 FEB 2011
© 2011 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 51, Issue 3, pages 392–402, March 2011
How to Cite
Ivanusic, J. J., Kwok, M. M.K., Ahn, A. H. and Jennings, E. A. (2011), 5-HT1D Receptor Immunoreactivity in the Sphenopalatine Ganglion: Implications for the Efficacy of Triptans in the Treatment of Autonomic Signs Associated With Cluster Headache. Headache: The Journal of Head and Face Pain, 51: 392–402. doi: 10.1111/j.1526-4610.2011.01843.x
Conflict of Interest: None
- Issue online: 25 FEB 2011
- Version of Record online: 25 FEB 2011
- Accepted for publication December 19, 2010.
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.